Skip to Main Content

Author Details

Scott R VandenBerg
University of California san francisco
1975
161
59
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36759733A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumors.Nat Cancer2023
36759733A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumors.Nat Cancer2023
35840578The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance.Nat Commun2022
35840578The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance.Nat Commun2022
33975958Genetically edited CD34[+] cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells.Proc Natl Acad Sci U S A2021
33975958Genetically edited CD34[+] cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells.Proc Natl Acad Sci U S A2021
34546978Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.JCI Insight2021
34546978Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.JCI Insight2021
33590360Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.J Mammary Gland Biol Neoplasia2020
33590360Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.J Mammary Gland Biol Neoplasia2020
30683736Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer.J Exp Med2019
31672976A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.Sci Data2019
30683736Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer.J Exp Med2019
30885981Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.Cancer Res2019
31672976A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.Sci Data2019
30885981Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.Cancer Res2019
27929677Assessing Researcher Needs for a Virtual Biobank.Biopreserv Biobank2017
27929677Assessing Researcher Needs for a Virtual Biobank.Biopreserv Biobank2017
28178237Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.Nature2017
28192480mTOR activity in AIDS-related diffuse large B-cell lymphoma.PLoS One2017
28192480mTOR activity in AIDS-related diffuse large B-cell lymphoma.PLoS One2017
28178237Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.Nature2017
27111386A 22-Year Old Woman with Right Eyelid Swelling.Brain Pathol2016
27155128Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.Neuroimage2016
27111386A 22-Year Old Woman with Right Eyelid Swelling.Brain Pathol2016
26420897Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.Neuro Oncol2016
26420897Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.Neuro Oncol2016
27155128Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.Neuroimage2016
25347738Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.Oncogene2015
25432173A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.Cancer Res2015
25347738Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.Oncogene2015
26231469Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI.Clin Radiol2015
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
26159421Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.Proc Natl Acad Sci U S A2015
26159421Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.Proc Natl Acad Sci U S A2015
26231469Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI.Clin Radiol2015
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
25432173A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.Cancer Res2015
24188809Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner.Neuroimage2014
25277177Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.Oncotarget2014
24309609Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.J Pediatr Hematol Oncol2014
24188809Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner.Neuroimage2014
25043047Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.Nature2014
25135423Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).J Neurooncol2014
2512119172 year old female with leg weakness.Brain Pathol2014
25277177Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.Oncotarget2014
25043047Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.Nature2014
2512119172 year old female with leg weakness.Brain Pathol2014
25135423Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).J Neurooncol2014
24309609Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.J Pediatr Hematol Oncol2014
  • 1 - 50 of 322

Recommended Authors

Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 6
Jo??lle Lacombe
centre hospitalier Sainte-Anne
Career Start Year 1999
Number of shared co-authors 8
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 22
Jorge A Gutierrez
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 13
Bj??rn Scheffler
German Cancer Research Center (DKFZ)
Career Start Year 1992
Number of shared co-authors 9
Johannes A Hainfellner
Medical University of Vienna
Career Start Year 1992
Number of shared co-authors 10
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 0
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 16
Sebastian Brandner
UCL Queen Square Institute of Neurology
Career Start Year 1989
Number of shared co-authors 24
Alexander O Vortmeyer
Indiana University School of Medicine
Career Start Year 1988
Number of shared co-authors 7
Ian F Pollack
University of Pittsburgh School of Medicine
Career Start Year 1987
Number of shared co-authors 51
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 46
Ho-Keung Ng
Chinese University of Hong Kong
Career Start Year 1987
Number of shared co-authors 49
Wies??awa Grajkowska
Children's Memorial Health Institute
Career Start Year 1987
Number of shared co-authors 51
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Career Start Year 1986
Number of shared co-authors 52
John Provias
McMaster University
Career Start Year 1986
Number of shared co-authors 7
Dragan Maric
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 4
William Halliday
University of Toronto
Career Start Year 1984
Number of shared co-authors 7
James T Rutka
Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 50
Arie Perry
University of California san francisco
Career Start Year 1984
Number of shared co-authors 68
Joshua B Rubin
Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 39
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1981
Number of shared co-authors 10
Scott L Pomeroy
Harvard Medical School
Career Start Year 1978
Number of shared co-authors 66
Anne Jouvet
Groupement Hospitalier EST, Universite de Lyon
Career Start Year 1976
Number of shared co-authors 44
Corey Raffel
University of California San Francisco
Career Start Year 1974
Number of shared co-authors 14
Mark Rosenblum
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 7
Boleslaw Lach
McMaster University
Career Start Year 1970
Number of shared co-authors 41
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 35
E. Tessa Hedley-Whyte
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Mitchel S Berger
University of California san francisco
Co-authored papers 21
Steven L Gonias
University of California san francisco
Co-authored papers 19
Charles D James
Co-authored papers 12
Michael W McDermott
University of California san francisco
Co-authored papers 10
Soonmee Cha
Co-authored papers 10
Michael D Prados
University of California san francisco
Co-authored papers 9
Frank B Furnari
University of California San Diego
Co-authored papers 8
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 8
Daphne A Haas-Kogan
Co-authored papers 7
Gabriele Bergers
VIB-Center for Cancer Biology
Co-authored papers 6
Takanori Hirose
Hyogo Cancer Center
Co-authored papers 5
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 5
John Graeme Hodgson
Co-authored papers 5
Claudia Petritsch
Co-authored papers 5
Joseph F Costello
University of California san francisco
Co-authored papers 5
Joanna J Phillips
University of California san francisco
Co-authored papers 4
Paul S Mischel
Stanford University
Co-authored papers 4
Bob S Carter
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
William A Weiss
University of California san francisco
Co-authored papers 4
Mei-Yin C Polley
Co-authored papers 4
Daniel A Lim
University of California san francisco
Co-authored papers 3
Steven G Britt
Co-authored papers 3
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 3
Anders I Persson
University of California san francisco
Co-authored papers 3
Stephen J DeArmond
Co-authored papers 3
Nicholas Butowski
University of California san francisco
Co-authored papers 3
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers 3
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Co-authored papers 3
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Release 1.2